http://orcid.org/0000-0001-7260-7686
References
- Basu, A., and Meltzer, D. (2007), “Value of Information on Preference Heterogeneity and Individualized Care,” Medical Decision Making, 27, 112–127. DOI: 10.1177/0272989X06297393.
- Berger, J. (1985), Statistical Decision Theory and Bayesian Analysis (2nd ed.), New York: Springer.
- Cheville, A., Almoza, M., Courmier, J., and Basford, J. (2010), “A Prospective Cohort Study Defining Utilities Using Time Trade-Offs and the Euroqol-5D to Assess the Impact of Cancer-Related Lymphedema,” Cancer, 116, 3722–3731. DOI: 10.1002/cncr.25068.
- Faries, M. (2018), “Completing the Dissection in Melanoma: Increasing Decision Precision,” Annals of Surgical Oncology, 25, 585–587, DOI: 10.1245/s10434-017-6330-4.
- Faries, M. B., Thompson, J. F., Cochran, A. J., Andtbacka, R. H., Mozzillo, N., Zager, J. S., Jahkola, T., Bowles, T. L., Testori, A., Beitsch, P. D., and Hoekstra, H. J. (2017), “Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma,” New England Journal of Medicine, 376, 2211–2222. DOI: 10.1056/NEJMoa1613210.
- Halpern, S., Karlawish, J., and Berlin, J. (2002), “The Continued Unethical Conduct of Underpowered Clinical Trials,” Journal of the American Medical Association, 288, 358–362. DOI: 10.1001/jama.288.3.358.
- International Conference on Harmonisation (1999), “ICH E9 Expert Working Group. Statistical Principles for Clinical Trials: ICH Harmonized Tripartite Guideline,” Statistics in Medicine, 18, 1905–1942.
- Manski, C. (2004), “Statistical Treatment Rules for Heterogeneous Populations,” Econometrica, 72, 221–246.
- Manski, C. (2019), “Treatment Choice With Trial Data: Statistical Decision Theory Should Supplant Hypothesis Testing,” The American Statistician.
- Manski, C., and Tetenov, A. (2016), “Sufficient Trial Size to Inform Clinical Practice,” Proceedings of the National Academy of Sciences, 113, 10518–10523. DOI: 10.1073/pnas.1612174113.
- Meltzer, D. (2001), “Addressing Uncertainty in Medical Cost-Effectiveness: Implications of Expected Utility Maximization for Methods to Perform Sensitivity Analysis and the Use of Cost-Effectiveness Analysis to Set Priorities for Medical Research,” Journal of Health Economics, 20, 109–129. DOI: 10.1016/S0167-6296(00)00071-0.
- Phelps, C., and Mushlin, A. (1988), “Focusing Technology Assessment Using Medical Decision Theory,” Medical Decision Making, 8, 279–289. DOI: 10.1177/0272989X8800800409.
- Press, W., Teukolsky, S., Vetterling, W., and Flannery, B. (2007), Numerical Recipes: The Art of Scientific Computing (3rd ed.), Cambridge: Cambridge University Press.
- Savage, L. (1951), “The Theory of Statistical Decision,” Journal of the American Statistical Association, 46, 55–67. DOI: 10.1080/01621459.1951.10500768.
- Spiegelhalter, D., Freedman, L., and Parmar, M. (1994), “Bayesian Approaches to Randomized Trials (with discussion),” Journal of the Royal Statistical Society, Series A, 157, 357–416. DOI: 10.2307/2983527.
- Stoye, J. (2009), “Minimax Regret Treatment Choice With Finite Samples,” Journal of Econometrics, 151, 70–81. DOI: 10.1016/j.jeconom.2009.02.013.
- Tetenov, A. (2016), “An Economic Theory of Statistical Testing,” Cemmap Working Paper CWP50/16.
- Wald, A. (1950), Statistical Decision Functions, New York: Wiley.